Towards bloodless cystectomy: a 10-year experience of intra-operative cell salvage during radical cystectomy. (abre una nueva ventana)

Aning J, Dunn J, Daugherty M, Mason R, Pocock R, Ridler B, Thompson J, McGrath JS.

Fuente‎: BJU Int 2012;110(11 Pt B):E608-13.

Indexado en‎: PubMed 22823412

DOI‎: 10.1111/j.1464-410X.2012.11338.x

https://www.ncbi.nlm.nih.gov/pubmed/22823412 (abre una nueva ventana)

Cell salvage as part of a blood conservation strategy in anaesthesia. (abre una nueva ventana)

Ashworth A, Klein AA.

Fuente‎: Br J Anaesth 2010;105(4):401-16.

Indexado en‎: PubMed 20802228

DOI‎: 10.1093/bja/aeq244

https://www.ncbi.nlm.nih.gov/pubmed/20802228 (abre una nueva ventana)

Cell salvage for minimising perioperative allogeneic blood transfusion. (abre una nueva ventana)

Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA.

Fuente‎: Cochrane Database Syst Rev 2010;(4):CD001888.

Indexado en‎: PubMed 20238316

DOI‎: 10.1002/14651858.CD001888.pub3

https://www.ncbi.nlm.nih.gov/pubmed/20238316 (abre una nueva ventana)

The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter. (abre una nueva ventana)

Edelman MJ, Potter P, Mahaffey KG, Frink R, Leidich RB.

Fuente‎: Urology 1996;47(2):179-81.

Indexado en‎: PubMed 8607229

DOI‎: 10.1016/S0090-4295(99)80411-7

https://www.ncbi.nlm.nih.gov/pubmed/8607229 (abre una nueva ventana)

Intra-operative cell salvage: a fresh look at the indications and contraindications. (abre una nueva ventana)

Esper SA, Waters JH.

Fuente‎: Blood Transfus 2011;9(2):139-47.

Indexado en‎: PubMed 21251468

DOI‎: 10.2450/2011.0081-10

https://www.ncbi.nlm.nih.gov/pubmed/21251468 (abre una nueva ventana)

Oncologic outcomes following radical prostatectomy with intraoperative cell salvage. (abre una nueva ventana)

Gorin MA, Eldefrawy A, Manoharan M, Soloway MS.

Fuente‎: World J Urol 2012;30(3):379-83.

Indexado en‎: PubMed 21847657

DOI‎: 10.1007/s00345-011-0746-4

https://www.ncbi.nlm.nih.gov/pubmed/21847657 (abre una nueva ventana)

Intraoperative cell salvage during radical cystectomy does not affect long-term survival. (abre una nueva ventana)

Nieder AM, Manoharan M, Yang Y, Soloway MS.

Fuente‎: Urology 2007;69(5):881-4.

Indexado en‎: PubMed 17482926

DOI‎: 10.1016/j.urology.2007.01.060

https://www.ncbi.nlm.nih.gov/pubmed/17482926 (abre una nueva ventana)

Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortality. (abre una nueva ventana)

Raval JS, Nelson JB, Woldemichael E, Triulzi DJ.

Fuente‎: Transfusion 2012;52(12):2590-3.

Indexado en‎: PubMed 22612661

DOI‎: 10.1111/j.1537-2995.2012.03682.x

https://www.ncbi.nlm.nih.gov/pubmed/22612661 (abre una nueva ventana)

Perioperative management including dual cell salvage in a Jehovah's Witness patient undergoing major urological surgery. (abre una nueva ventana)

Smith TG, Anastasescu I, Wight JM, Danaee A, Nair R, O'Brien TS

Fuente‎: Clin Case Rep 2021;9(11):e05098.

Indexado en‎: PubMed 34824851

DOI‎: 10.1002/ccr3.5098

https://pubmed.ncbi.nlm.nih.gov/34824851/ (abre una nueva ventana)

Should intraoperative cell-salvaged blood be used in patients with suspected or known malignancy? (abre una nueva ventana)

Trudeau JD, Waters T, Chipperfield K.

Fuente‎: Can J Anaesth 2012;59(11):1058-70.

Indexado en‎: PubMed 22996966

DOI‎: 10.1007/s12630-012-9781-x

https://www.ncbi.nlm.nih.gov/pubmed/22996966 (abre una nueva ventana)

Intraoperative red blood cell salvage and autologous transfusion during open radical retropubic prostatectomy: a cost-benefit analysis. (abre una nueva ventana)

Ubee S, Kumar M, Athmanathan N, Singh G, Vesey S.

Fuente‎: Ann R Coll Surg Engl 2011;93(2):157-61.

Indexado en‎: PubMed 22041147

DOI‎: 10.1308/003588411X561044

https://www.ncbi.nlm.nih.gov/pubmed/22041147 (abre una nueva ventana)

Blood salvage and cancer surgery: a meta-analysis of available studies. (abre una nueva ventana)

Waters JH, Yazer M, Chen YF, Kloke J.

Fuente‎: Transfusion 2012;52(10):2167-73.

Indexado en‎: PubMed 22321196

DOI‎: 10.1111/j.1537-2995.2011.03555.x

https://www.ncbi.nlm.nih.gov/pubmed/22321196 (abre una nueva ventana)

Blood conservation strategies to minimize allogeneic blood use in urologic surgery. (abre una nueva ventana)

Monk TG, Goodnough LT.

Fuente‎: Am J Surg 1995;170(6A Suppl):69S-73S.

Indexado en‎: PubMed 8546252

https://www.ncbi.nlm.nih.gov/pubmed/8546252 (abre una nueva ventana)

Acute normovolemic hemodilution. (abre una nueva ventana)

Monk TG.

Fuente‎: Anesthesiol Clin North America 2005;23(2):271-81.

Indexado en‎: PubMed 15922899

DOI‎: 10.1016/j.atc.2005.03.002

https://www.ncbi.nlm.nih.gov/pubmed/15922899 (abre una nueva ventana)

Acute normovolemic hemodilution. (abre una nueva ventana)

Shander A, Rijhwani TS.

Fuente‎: Transfusion 2004;44(12 Suppl):26S-34S.

Indexado en‎: PubMed 15585002

DOI‎: 10.1111/j.0041-1132.2004.04293.x

https://www.ncbi.nlm.nih.gov/pubmed/15585002 (abre una nueva ventana)

Acute normovolemic hemodilution for radical prostatectomy: can it replace preoperative autologous blood transfusion? (abre una nueva ventana)

Terada N, Arai Y, Matsuta Y, Maekawa S, Okubo K, Ogura K, Matsuda N, Yonei A.

Fuente‎: Int J Urol 2001;8(4):149-52.

Indexado en‎: PubMed 11260345

https://www.ncbi.nlm.nih.gov/pubmed/11260345 (abre una nueva ventana)

Предоперацонная гиперволемическая гемодилюция 6% гидроксиэтил-крахмалом 130/0,4 (HES 130/0,4) как способ сокращения потребности в трансфузии донорской крови. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion.] [Russian, English abstract] (abre una nueva ventana)

Winter V, Gille J, Richter A, Sablotzki A, Wiedemann B.

Fuente‎: Anesteziol Reanimatol 2006;163(2):43-7.

Indexado en‎: PubMed 16758944

https://www.ncbi.nlm.nih.gov/pubmed/16758944 (abre una nueva ventana)